Orange Book product · Generic (ANDA)
MUPIROCIN
MUPIROCIN
Generic (ANDA)ANDA 065123TE ABRX PADAGIS ISRAEL
At a glance
Nov 07, 2003
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Nov 07, 2003
22 yr 11 mo ago
Today
Pharmaceutical detail
Active ingredient
MUPIROCIN
Strength
2%
Dosage form
OINTMENT
Route
TOPICAL
TE code
AB
Application
ANDA 065123
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
Yes
Active-ingredient family
View full familyGeneric (ANDA) of MUPIROCIN
- 2002CENTANYBrand (NDA)
NDA 050788 · PADAGIS US
- 1987BACTROBANBrand (NDA)
NDA 050591 · GLAXOSMITHKLINE
- 2025MUPIROCINGeneric (ANDA)
ANDA 217943 · ENCUBE
- 2011MUPIROCINGeneric (ANDA)
ANDA 090480 · GLENMARK PHARMS
- 2005MUPIROCINGeneric (ANDA)
ANDA 065192 · FOUGERA PHARMS
- 2005MUPIROCINGeneric (ANDA)
ANDA 065170 · SUN PHARMA CANADA
- 2003MUPIROCINGeneric (ANDA)
ANDA 065085 · TEVA
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
